• Investors and Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
    • Financials and SEC Filings
    • Annual Meeting
    • Stock Information
    • Analyst Coverage
    • Investor FAQs
    • Resources
    • Email Alerts
  • Healthcare Providers
  • Contact Us
Search
Arvinas Logo
Arvinas logo
  • Our Science
    • Overview
    • PROTAC Discovery Engine
    • Scientific Publications
    • Partnerships
  • Pipeline and Research
    • Overview
    • Pipeline
    • Breast Cancer
    • Neuroscience
  • About Us
    • Overview
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Board
  • Patients
    • Overview
    • Patients with Breast Cancer
    • Clinical Trials
    • Expanded Access Policy
  • Careers and Culture
    • Overview
    • Open Positions
    • Life in New Haven
    • Our Values
    • Benefits
    • Giving Back
Search
  • Our Science
    • Overview
    • PROTAC Discovery Engine
    • Scientific Publications
    • Partnerships
  • Pipeline and Research
    • Overview
    • Pipeline
    • Breast Cancer
    • Neuroscience
  • About Us
    • Overview
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Board
  • Patients
    • Overview
    • Patients with Breast Cancer
    • Clinical Trials
    • Expanded Access Policy
  • Careers and Culture
    • Overview
    • Open Positions
    • Life in New Haven
    • Our Values
    • Benefits
    • Giving Back
  • Investors and Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
    • Financials and SEC Filings
    • Annual Meeting
    • Stock Information
    • Analyst Coverage
    • Investor FAQs
    • Resources
    • Email Alerts
  • Healthcare Providers
  • Contact Us
Porto Placeholder
Kimberly Wehger Senior Vice President of Information Technology Systems and Security
Porto Placeholder
Janet Wang, Ph.D. Vice President and Head of Translational Sciences, Oncology
Porto Placeholder
Shiva Sekhar Vice President of Global and U.S. Marketing for Breast Cancer
Alex Santini
Alex Santini Interim Chief Commercial Officer and Senior Vice President of Global and U.S. Market Access
Porto Placeholder
Charlie Romano Vice President, Global Development Operations
Porto Placeholder
Achal Pashine, M.Sc., Ph.D. Vice President of Oncology and Immuno-Oncology Research
Porto Placeholder
John Obourn, Ph.D. Vice President, Androgen Receptor Global Asset Lead
Porto Placeholder
Eric Masson, Pharm.D. Senior Vice President, Early Clinical Development
Porto Placeholder
David Loomis, C.P.A. Vice President, Corporate Controller and Chief Accounting Officer
Porto Placeholder
Brad Lanoue Vice President of Global and U.S. Value and Market Access Strategy
  Prev1234…6Next  
Arvinas logo
  • Healthcare Providers
  • Careers
  • Privacy Policy
  • Terms of Use
LinkedIn
X

Accessibility Statement

© 2025 Arvinas. All rights reserved.

Arvinas

You are now leaving arvinas.com. Arvinas does not endorse or recommend the content in any third-party sites. Arvinas is not responsible and disclaims liability for the content, or for any viruses or similar harmful programs, that may be present on third-party pages or sites. Visits to a third-party website are at your own risk and subject to the terms and conditions and privacy policy of such site.

GO BACK
CONTINUE